Motif ID: Tgif1_Meis3
Z-value: 4.395
Transcription factors associated with Tgif1_Meis3:
| Gene Symbol | Entrez ID | Gene Name |
|---|---|---|
| Meis3 | ENSMUSG00000041420.12 | Meis3 |
| Tgif1 | ENSMUSG00000047407.11 | Tgif1 |
Activity-expression correlation:
| Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| Tgif1 | mm10_v2_chr17_-_70851710_70851738 | -0.89 | 5.6e-07 | Click! |
| Meis3 | mm10_v2_chr7_+_16175085_16175139 | 0.67 | 2.2e-03 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 11.1 | 44.3 | GO:0021564 | glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 5.6 | 22.6 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
| 5.6 | 22.5 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
| 4.2 | 8.4 | GO:0042323 | negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 4.1 | 12.4 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
| 3.9 | 11.7 | GO:0003349 | epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
| 3.8 | 3.8 | GO:0055015 | ventricular cardiac muscle cell development(GO:0055015) |
| 3.4 | 10.2 | GO:0007521 | muscle cell fate determination(GO:0007521) |
| 2.4 | 7.1 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
| 2.4 | 7.1 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
| 2.3 | 16.1 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 2.3 | 29.8 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 2.1 | 6.4 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
| 2.1 | 4.3 | GO:0046110 | xanthine metabolic process(GO:0046110) |
| 2.1 | 8.5 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
| 2.0 | 6.1 | GO:1903011 | negative regulation of bone development(GO:1903011) |
| 2.0 | 10.1 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 2.0 | 9.8 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 1.9 | 11.6 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 1.9 | 7.5 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 1.9 | 7.4 | GO:0048686 | regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 1.7 | 6.8 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
| 1.6 | 6.6 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
| 1.6 | 6.5 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
| 1.5 | 7.6 | GO:2000551 | regulation of T-helper 2 cell cytokine production(GO:2000551) positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
| 1.5 | 7.5 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
| 1.4 | 4.2 | GO:0043987 | histone-serine phosphorylation(GO:0035404) histone H3-S10 phosphorylation(GO:0043987) |
| 1.4 | 4.2 | GO:1902277 | negative regulation of pancreatic amylase secretion(GO:1902277) |
| 1.3 | 4.0 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 1.3 | 6.7 | GO:0098706 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 1.3 | 3.9 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
| 1.3 | 2.6 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
| 1.2 | 8.5 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 1.2 | 4.8 | GO:0051933 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
| 1.2 | 3.6 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
| 1.2 | 7.2 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
| 1.2 | 2.3 | GO:0031554 | regulation of DNA-templated transcription, termination(GO:0031554) |
| 1.2 | 3.5 | GO:0043379 | memory T cell differentiation(GO:0043379) negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 1.1 | 5.7 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 1.1 | 8.0 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 1.1 | 4.5 | GO:1903764 | regulation of potassium ion export across plasma membrane(GO:1903764) |
| 1.1 | 3.3 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 1.1 | 9.7 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
| 1.1 | 8.6 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
| 1.1 | 3.2 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 1.1 | 5.3 | GO:0051182 | coenzyme transport(GO:0051182) |
| 1.1 | 8.5 | GO:0090166 | Golgi disassembly(GO:0090166) |
| 1.0 | 3.1 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 1.0 | 4.1 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
| 1.0 | 6.0 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 1.0 | 4.0 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 1.0 | 11.8 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 1.0 | 2.9 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
| 0.9 | 4.5 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
| 0.9 | 7.1 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
| 0.9 | 7.0 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.8 | 2.5 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) regulation of microglial cell activation(GO:1903978) telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 0.8 | 2.5 | GO:0042560 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.8 | 4.1 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
| 0.8 | 2.4 | GO:0007403 | glial cell fate determination(GO:0007403) |
| 0.8 | 1.6 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
| 0.8 | 4.6 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.8 | 1.5 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.8 | 3.0 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
| 0.7 | 0.7 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
| 0.7 | 2.2 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
| 0.7 | 4.4 | GO:0019695 | choline metabolic process(GO:0019695) |
| 0.7 | 3.6 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
| 0.7 | 3.6 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
| 0.7 | 2.2 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
| 0.7 | 2.2 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
| 0.7 | 0.7 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
| 0.7 | 5.0 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
| 0.7 | 1.4 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) |
| 0.7 | 7.8 | GO:0010650 | positive regulation of cell communication by electrical coupling(GO:0010650) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.7 | 2.8 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
| 0.7 | 5.6 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
| 0.7 | 8.4 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.7 | 6.3 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.7 | 2.1 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
| 0.7 | 3.4 | GO:0090292 | nuclear migration along microfilament(GO:0031022) nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.7 | 4.1 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 0.7 | 2.7 | GO:1990743 | protein sialylation(GO:1990743) |
| 0.7 | 2.0 | GO:0014735 | regulation of muscle atrophy(GO:0014735) |
| 0.7 | 2.7 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
| 0.7 | 3.3 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
| 0.7 | 3.3 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
| 0.7 | 19.7 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
| 0.6 | 5.2 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
| 0.6 | 12.2 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
| 0.6 | 2.6 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.6 | 1.9 | GO:0002159 | desmosome assembly(GO:0002159) |
| 0.6 | 1.9 | GO:1903061 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) regulation of protein lipidation(GO:1903059) positive regulation of protein lipidation(GO:1903061) |
| 0.6 | 0.6 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
| 0.6 | 0.6 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 0.6 | 5.0 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
| 0.6 | 1.9 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) |
| 0.6 | 5.5 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.6 | 8.6 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.6 | 1.2 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.6 | 5.4 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
| 0.6 | 3.0 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.6 | 4.8 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.6 | 1.8 | GO:0070428 | granuloma formation(GO:0002432) negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) toll-like receptor 5 signaling pathway(GO:0034146) regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070432) |
| 0.6 | 1.7 | GO:1900369 | negative regulation of RNA interference(GO:1900369) |
| 0.6 | 1.7 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
| 0.6 | 1.7 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
| 0.6 | 1.7 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.6 | 1.7 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) |
| 0.6 | 3.4 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.6 | 2.8 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.6 | 5.0 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
| 0.6 | 8.3 | GO:0097090 | presynaptic membrane organization(GO:0097090) |
| 0.6 | 1.7 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.5 | 2.2 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.5 | 5.4 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 0.5 | 1.6 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
| 0.5 | 1.6 | GO:0090004 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 0.5 | 1.6 | GO:1900365 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.5 | 4.2 | GO:1903207 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
| 0.5 | 7.8 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
| 0.5 | 1.6 | GO:0042196 | dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
| 0.5 | 1.0 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
| 0.5 | 0.5 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
| 0.5 | 19.6 | GO:0006376 | mRNA splice site selection(GO:0006376) |
| 0.5 | 1.5 | GO:0046880 | regulation of follicle-stimulating hormone secretion(GO:0046880) follicle-stimulating hormone secretion(GO:0046884) |
| 0.5 | 3.4 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
| 0.5 | 1.5 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) |
| 0.5 | 0.5 | GO:0071317 | cellular response to isoquinoline alkaloid(GO:0071317) |
| 0.5 | 4.3 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
| 0.5 | 7.6 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.5 | 1.4 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) |
| 0.5 | 1.4 | GO:0060022 | hard palate development(GO:0060022) |
| 0.5 | 5.2 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
| 0.5 | 2.8 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) |
| 0.5 | 3.7 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
| 0.5 | 4.7 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
| 0.5 | 11.1 | GO:0021860 | pyramidal neuron development(GO:0021860) |
| 0.5 | 1.4 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
| 0.5 | 1.4 | GO:0097309 | cap1 mRNA methylation(GO:0097309) |
| 0.5 | 29.8 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 0.4 | 1.8 | GO:0070305 | response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
| 0.4 | 2.7 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
| 0.4 | 1.7 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
| 0.4 | 3.9 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.4 | 1.3 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.4 | 2.6 | GO:0046549 | retinal cone cell development(GO:0046549) |
| 0.4 | 2.6 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.4 | 2.1 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
| 0.4 | 1.3 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
| 0.4 | 4.6 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
| 0.4 | 0.8 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.4 | 2.5 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.4 | 6.3 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
| 0.4 | 3.8 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.4 | 0.4 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
| 0.4 | 1.7 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.4 | 0.8 | GO:0060266 | regulation of respiratory burst involved in inflammatory response(GO:0060264) negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
| 0.4 | 2.1 | GO:0097646 | dimeric G-protein coupled receptor signaling pathway(GO:0038042) calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.4 | 1.2 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
| 0.4 | 1.2 | GO:0034035 | sulfate assimilation(GO:0000103) purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.4 | 2.0 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 0.4 | 2.4 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.4 | 1.2 | GO:0060854 | patterning of lymph vessels(GO:0060854) |
| 0.4 | 1.6 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 0.4 | 2.4 | GO:1904953 | Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904953) |
| 0.4 | 2.0 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.4 | 2.3 | GO:0045332 | phospholipid translocation(GO:0045332) |
| 0.4 | 2.3 | GO:0010359 | regulation of anion channel activity(GO:0010359) |
| 0.4 | 1.9 | GO:0070417 | cellular response to cold(GO:0070417) |
| 0.4 | 1.2 | GO:1903538 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
| 0.4 | 1.1 | GO:0090327 | negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
| 0.4 | 1.1 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
| 0.4 | 3.0 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.4 | 3.3 | GO:0071420 | cellular response to histamine(GO:0071420) |
| 0.4 | 1.9 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
| 0.4 | 1.1 | GO:1900149 | positive regulation of Schwann cell migration(GO:1900149) |
| 0.4 | 1.8 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
| 0.4 | 2.5 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.4 | 1.1 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.4 | 3.2 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
| 0.3 | 2.1 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 0.3 | 2.4 | GO:0015808 | L-alanine transport(GO:0015808) |
| 0.3 | 1.7 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
| 0.3 | 3.1 | GO:0036371 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
| 0.3 | 1.7 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
| 0.3 | 3.7 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.3 | 5.4 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
| 0.3 | 3.4 | GO:0002327 | immature B cell differentiation(GO:0002327) |
| 0.3 | 5.1 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.3 | 1.0 | GO:0009174 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.3 | 2.6 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
| 0.3 | 1.6 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.3 | 1.0 | GO:0010896 | regulation of triglyceride catabolic process(GO:0010896) positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.3 | 1.0 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
| 0.3 | 1.3 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
| 0.3 | 2.3 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.3 | 1.6 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
| 0.3 | 4.7 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.3 | 2.5 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.3 | 0.9 | GO:0043181 | vacuolar sequestering(GO:0043181) |
| 0.3 | 1.2 | GO:1904528 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
| 0.3 | 2.5 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
| 0.3 | 0.9 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 0.3 | 12.1 | GO:0034605 | cellular response to heat(GO:0034605) |
| 0.3 | 0.6 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
| 0.3 | 1.8 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
| 0.3 | 1.8 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
| 0.3 | 0.6 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
| 0.3 | 1.5 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
| 0.3 | 0.6 | GO:0061724 | lipophagy(GO:0061724) |
| 0.3 | 0.9 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
| 0.3 | 2.0 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
| 0.3 | 2.3 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
| 0.3 | 2.8 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.3 | 2.5 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.3 | 2.2 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
| 0.3 | 0.8 | GO:0007525 | somatic muscle development(GO:0007525) |
| 0.3 | 0.3 | GO:1903943 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
| 0.3 | 1.3 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
| 0.3 | 0.5 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
| 0.3 | 1.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
| 0.3 | 1.3 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
| 0.3 | 0.8 | GO:0031038 | myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
| 0.3 | 3.1 | GO:2000480 | regulation of cAMP-dependent protein kinase activity(GO:2000479) negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.3 | 0.8 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
| 0.3 | 6.6 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.3 | 0.5 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
| 0.3 | 1.3 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.3 | 3.8 | GO:0097120 | receptor localization to synapse(GO:0097120) |
| 0.3 | 0.3 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
| 0.2 | 1.0 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
| 0.2 | 1.5 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
| 0.2 | 0.7 | GO:0044028 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.2 | 2.2 | GO:0098780 | response to mitochondrial depolarisation(GO:0098780) |
| 0.2 | 1.7 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
| 0.2 | 1.2 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.2 | 1.9 | GO:0070314 | G1 to G0 transition(GO:0070314) |
| 0.2 | 0.9 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.2 | 0.9 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.2 | 3.8 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
| 0.2 | 1.2 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 0.2 | 1.2 | GO:0036508 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
| 0.2 | 3.2 | GO:0071625 | vocalization behavior(GO:0071625) |
| 0.2 | 0.9 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.2 | 3.1 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
| 0.2 | 2.0 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.2 | 2.5 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.2 | 0.4 | GO:0070874 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.2 | 0.7 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
| 0.2 | 1.5 | GO:0032261 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
| 0.2 | 0.9 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
| 0.2 | 1.5 | GO:0019985 | translesion synthesis(GO:0019985) |
| 0.2 | 3.7 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.2 | 1.1 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
| 0.2 | 4.4 | GO:0009200 | deoxyribonucleoside triphosphate metabolic process(GO:0009200) |
| 0.2 | 0.2 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
| 0.2 | 4.2 | GO:0060117 | auditory receptor cell development(GO:0060117) |
| 0.2 | 0.6 | GO:0071544 | diphosphoinositol polyphosphate catabolic process(GO:0071544) |
| 0.2 | 3.9 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
| 0.2 | 1.8 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
| 0.2 | 2.4 | GO:0044144 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
| 0.2 | 0.6 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.2 | 3.6 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
| 0.2 | 13.4 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
| 0.2 | 1.8 | GO:0010818 | T cell chemotaxis(GO:0010818) |
| 0.2 | 1.2 | GO:0021540 | corpus callosum morphogenesis(GO:0021540) |
| 0.2 | 1.4 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
| 0.2 | 0.6 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
| 0.2 | 0.8 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.2 | 0.6 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
| 0.2 | 0.4 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.2 | 0.8 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.2 | 1.4 | GO:0008090 | retrograde axonal transport(GO:0008090) |
| 0.2 | 0.4 | GO:1903406 | regulation of sodium:potassium-exchanging ATPase activity(GO:1903406) |
| 0.2 | 0.2 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 0.2 | 8.1 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.2 | 0.4 | GO:0070142 | synaptic vesicle budding(GO:0070142) |
| 0.2 | 0.9 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.2 | 2.8 | GO:0002335 | mature B cell differentiation(GO:0002335) |
| 0.2 | 0.9 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
| 0.2 | 0.2 | GO:0098792 | xenophagy(GO:0098792) regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
| 0.2 | 0.4 | GO:0090649 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
| 0.2 | 0.6 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.2 | 1.6 | GO:0070842 | aggresome assembly(GO:0070842) |
| 0.2 | 1.8 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
| 0.2 | 0.9 | GO:0002326 | B cell lineage commitment(GO:0002326) |
| 0.2 | 4.0 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
| 0.2 | 6.5 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
| 0.2 | 0.7 | GO:0015871 | choline transport(GO:0015871) |
| 0.2 | 2.3 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.2 | 1.8 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) negative regulation of protein homooligomerization(GO:0032463) |
| 0.2 | 2.1 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
| 0.2 | 2.3 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
| 0.2 | 4.7 | GO:0061157 | mRNA destabilization(GO:0061157) |
| 0.2 | 1.0 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 0.2 | 1.2 | GO:0046541 | saliva secretion(GO:0046541) |
| 0.2 | 1.9 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
| 0.2 | 1.9 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.2 | 0.7 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.2 | 0.9 | GO:0036337 | Fas signaling pathway(GO:0036337) |
| 0.2 | 1.7 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.2 | 13.0 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.2 | 1.8 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.2 | 1.5 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
| 0.2 | 2.2 | GO:0042092 | type 2 immune response(GO:0042092) |
| 0.2 | 6.3 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
| 0.2 | 1.8 | GO:2000580 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.2 | 1.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
| 0.2 | 1.0 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
| 0.2 | 0.7 | GO:2000858 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) positive regulation of mineralocorticoid secretion(GO:2000857) regulation of aldosterone secretion(GO:2000858) positive regulation of aldosterone secretion(GO:2000860) |
| 0.2 | 1.6 | GO:0032527 | retrograde protein transport, ER to cytosol(GO:0030970) protein exit from endoplasmic reticulum(GO:0032527) |
| 0.2 | 1.8 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
| 0.2 | 0.6 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.2 | 0.8 | GO:0021508 | floor plate formation(GO:0021508) floor plate morphogenesis(GO:0033505) |
| 0.2 | 1.4 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
| 0.2 | 0.6 | GO:0070829 | heterochromatin maintenance(GO:0070829) |
| 0.2 | 1.6 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.2 | 0.8 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.2 | 1.2 | GO:0045176 | apical protein localization(GO:0045176) |
| 0.2 | 0.9 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
| 0.1 | 0.9 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
| 0.1 | 1.9 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
| 0.1 | 1.0 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.1 | 4.0 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.1 | 10.3 | GO:0030032 | lamellipodium assembly(GO:0030032) |
| 0.1 | 0.6 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
| 0.1 | 0.4 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.1 | 0.3 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.1 | 0.1 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
| 0.1 | 3.2 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.1 | 1.3 | GO:0042119 | neutrophil activation(GO:0042119) |
| 0.1 | 0.4 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.1 | 1.0 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.1 | 1.0 | GO:0030242 | pexophagy(GO:0030242) |
| 0.1 | 1.0 | GO:0019532 | oxalate transport(GO:0019532) |
| 0.1 | 3.3 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
| 0.1 | 0.6 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.1 | 0.6 | GO:0061010 | gall bladder development(GO:0061010) |
| 0.1 | 0.4 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
| 0.1 | 2.2 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
| 0.1 | 0.4 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.1 | 0.3 | GO:1905203 | regulation of connective tissue replacement(GO:1905203) |
| 0.1 | 1.7 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
| 0.1 | 0.4 | GO:0021603 | cranial nerve formation(GO:0021603) |
| 0.1 | 1.2 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 0.1 | 2.6 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
| 0.1 | 0.3 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.1 | 0.8 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.1 | 0.8 | GO:0006108 | malate metabolic process(GO:0006108) |
| 0.1 | 0.9 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.1 | 0.4 | GO:0019085 | early viral transcription(GO:0019085) |
| 0.1 | 1.1 | GO:0030539 | male genitalia development(GO:0030539) |
| 0.1 | 1.7 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
| 0.1 | 0.7 | GO:0098707 | iron ion import into cell(GO:0097459) ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) iron ion import across plasma membrane(GO:0098711) |
| 0.1 | 1.2 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
| 0.1 | 2.7 | GO:0032094 | response to food(GO:0032094) |
| 0.1 | 0.5 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
| 0.1 | 0.5 | GO:0097298 | regulation of nucleus size(GO:0097298) |
| 0.1 | 1.1 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.1 | 0.6 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
| 0.1 | 0.1 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
| 0.1 | 0.5 | GO:0006689 | ganglioside catabolic process(GO:0006689) oligosaccharide catabolic process(GO:0009313) |
| 0.1 | 0.6 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.1 | 0.5 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
| 0.1 | 0.3 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
| 0.1 | 0.3 | GO:1901911 | diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.1 | 0.6 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
| 0.1 | 3.1 | GO:0032456 | endocytic recycling(GO:0032456) |
| 0.1 | 0.3 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
| 0.1 | 0.4 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
| 0.1 | 1.3 | GO:0007097 | nuclear migration(GO:0007097) establishment of nucleus localization(GO:0040023) |
| 0.1 | 0.6 | GO:0008228 | opsonization(GO:0008228) |
| 0.1 | 0.3 | GO:0060155 | platelet dense granule organization(GO:0060155) |
| 0.1 | 0.3 | GO:0003345 | proepicardium cell migration involved in pericardium morphogenesis(GO:0003345) |
| 0.1 | 0.6 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.1 | 2.0 | GO:0032414 | positive regulation of ion transmembrane transporter activity(GO:0032414) |
| 0.1 | 1.5 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
| 0.1 | 0.7 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
| 0.1 | 0.4 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
| 0.1 | 1.0 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
| 0.1 | 0.4 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
| 0.1 | 4.1 | GO:0030042 | actin filament depolymerization(GO:0030042) |
| 0.1 | 2.9 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
| 0.1 | 0.9 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
| 0.1 | 0.6 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
| 0.1 | 0.3 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
| 0.1 | 0.5 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
| 0.1 | 0.6 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.1 | 2.5 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
| 0.1 | 0.5 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
| 0.1 | 0.1 | GO:0070494 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
| 0.1 | 0.5 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
| 0.1 | 1.5 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
| 0.1 | 1.8 | GO:0006308 | DNA catabolic process(GO:0006308) |
| 0.1 | 0.3 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
| 0.1 | 1.4 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
| 0.1 | 0.7 | GO:0006983 | ER overload response(GO:0006983) |
| 0.1 | 1.0 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
| 0.1 | 0.5 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 0.1 | 0.2 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
| 0.1 | 0.5 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
| 0.1 | 1.6 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
| 0.1 | 2.3 | GO:0050919 | negative chemotaxis(GO:0050919) |
| 0.1 | 2.8 | GO:0051453 | regulation of intracellular pH(GO:0051453) |
| 0.1 | 0.7 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 0.1 | 0.4 | GO:1903756 | regulation of postsynaptic density protein 95 clustering(GO:1902897) regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 0.1 | 9.6 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
| 0.1 | 2.3 | GO:0046834 | lipid phosphorylation(GO:0046834) |
| 0.1 | 1.8 | GO:0001964 | startle response(GO:0001964) |
| 0.1 | 0.2 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
| 0.1 | 1.4 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.1 | 0.6 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
| 0.1 | 1.1 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
| 0.1 | 0.7 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
| 0.1 | 0.9 | GO:0030953 | astral microtubule organization(GO:0030953) |
| 0.1 | 0.8 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.1 | 0.6 | GO:0042126 | nitrate metabolic process(GO:0042126) |
| 0.1 | 0.2 | GO:0022038 | corpus callosum development(GO:0022038) |
| 0.1 | 1.9 | GO:0043113 | receptor clustering(GO:0043113) |
| 0.1 | 0.2 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
| 0.1 | 0.3 | GO:0090630 | activation of GTPase activity(GO:0090630) |
| 0.1 | 1.3 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.1 | 0.4 | GO:0030223 | neutrophil differentiation(GO:0030223) |
| 0.1 | 1.1 | GO:1903078 | positive regulation of protein localization to plasma membrane(GO:1903078) |
| 0.1 | 0.3 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
| 0.1 | 4.4 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.1 | 0.6 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.1 | 0.7 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
| 0.1 | 10.5 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
| 0.1 | 0.4 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
| 0.1 | 0.2 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.1 | 1.0 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 0.1 | 0.6 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.1 | 0.6 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
| 0.1 | 0.5 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 0.1 | 0.8 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.1 | 6.2 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
| 0.1 | 0.5 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
| 0.1 | 2.2 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.1 | 0.5 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
| 0.1 | 1.5 | GO:0046850 | regulation of bone remodeling(GO:0046850) |
| 0.1 | 1.8 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
| 0.1 | 0.4 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.1 | 1.5 | GO:0061462 | protein localization to lysosome(GO:0061462) |
| 0.1 | 0.6 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
| 0.1 | 0.6 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.1 | 1.1 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
| 0.1 | 1.6 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
| 0.1 | 0.9 | GO:0060444 | branching involved in mammary gland duct morphogenesis(GO:0060444) |
| 0.1 | 0.3 | GO:0015889 | cobalamin transport(GO:0015889) |
| 0.1 | 0.6 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.1 | 0.6 | GO:1900048 | positive regulation of blood coagulation(GO:0030194) positive regulation of hemostasis(GO:1900048) |
| 0.1 | 2.5 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
| 0.1 | 0.7 | GO:1990090 | response to nerve growth factor(GO:1990089) cellular response to nerve growth factor stimulus(GO:1990090) |
| 0.1 | 0.3 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.1 | 1.1 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
| 0.1 | 0.3 | GO:0051231 | mitotic spindle elongation(GO:0000022) spindle elongation(GO:0051231) mitotic spindle midzone assembly(GO:0051256) |
| 0.1 | 0.4 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
| 0.1 | 6.8 | GO:0010977 | negative regulation of neuron projection development(GO:0010977) |
| 0.1 | 0.1 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
| 0.1 | 0.1 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.1 | 0.2 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
| 0.1 | 2.7 | GO:0003073 | regulation of systemic arterial blood pressure(GO:0003073) |
| 0.1 | 0.5 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
| 0.1 | 1.3 | GO:0021591 | ventricular system development(GO:0021591) |
| 0.1 | 0.3 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
| 0.1 | 0.5 | GO:0001659 | temperature homeostasis(GO:0001659) |
| 0.1 | 1.5 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.1 | 1.8 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
| 0.1 | 2.5 | GO:0048286 | lung alveolus development(GO:0048286) |
| 0.1 | 1.7 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
| 0.1 | 0.6 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
| 0.1 | 0.4 | GO:0001675 | acrosome assembly(GO:0001675) |
| 0.1 | 0.5 | GO:0005980 | polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.1 | 0.2 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 0.1 | 0.5 | GO:0015809 | arginine transport(GO:0015809) |
| 0.1 | 2.3 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
| 0.1 | 2.7 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
| 0.1 | 1.0 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.1 | 0.6 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
| 0.1 | 0.2 | GO:0032364 | oxygen homeostasis(GO:0032364) |
| 0.1 | 0.2 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
| 0.1 | 1.0 | GO:0071539 | protein localization to centrosome(GO:0071539) |
| 0.1 | 0.9 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
| 0.0 | 0.9 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
| 0.0 | 0.6 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
| 0.0 | 0.1 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
| 0.0 | 1.6 | GO:2000378 | negative regulation of reactive oxygen species metabolic process(GO:2000378) |
| 0.0 | 1.0 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
| 0.0 | 0.3 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
| 0.0 | 0.5 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
| 0.0 | 0.6 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
| 0.0 | 0.5 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
| 0.0 | 1.0 | GO:0010955 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
| 0.0 | 0.1 | GO:0070166 | enamel mineralization(GO:0070166) |
| 0.0 | 0.2 | GO:0070627 | vanadium ion transport(GO:0015676) lead ion transport(GO:0015692) ferrous iron import(GO:0070627) |
| 0.0 | 4.0 | GO:0008643 | carbohydrate transport(GO:0008643) |
| 0.0 | 1.0 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
| 0.0 | 2.1 | GO:0050806 | positive regulation of synaptic transmission(GO:0050806) |
| 0.0 | 1.5 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
| 0.0 | 2.2 | GO:0009166 | nucleotide catabolic process(GO:0009166) |
| 0.0 | 0.5 | GO:0035455 | response to interferon-alpha(GO:0035455) |
| 0.0 | 0.7 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.0 | 0.8 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
| 0.0 | 1.3 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
| 0.0 | 0.2 | GO:0016079 | synaptic vesicle exocytosis(GO:0016079) |
| 0.0 | 0.4 | GO:0048278 | vesicle docking(GO:0048278) |
| 0.0 | 0.7 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.0 | 0.3 | GO:0070995 | toxin metabolic process(GO:0009404) NADPH oxidation(GO:0070995) |
| 0.0 | 0.0 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
| 0.0 | 0.3 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
| 0.0 | 0.3 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
| 0.0 | 0.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.0 | 0.0 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) |
| 0.0 | 0.2 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
| 0.0 | 0.2 | GO:0048793 | pronephros development(GO:0048793) |
| 0.0 | 0.5 | GO:0009299 | mRNA transcription(GO:0009299) |
| 0.0 | 0.2 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.0 | 0.2 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.0 | 0.1 | GO:0051295 | parallel actin filament bundle assembly(GO:0030046) polar body extrusion after meiotic divisions(GO:0040038) establishment of meiotic spindle localization(GO:0051295) formin-nucleated actin cable assembly(GO:0070649) |
| 0.0 | 0.4 | GO:0044804 | nucleophagy(GO:0044804) |
| 0.0 | 0.3 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
| 0.0 | 0.1 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
| 0.0 | 0.3 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.0 | 0.5 | GO:0007020 | microtubule nucleation(GO:0007020) |
| 0.0 | 0.9 | GO:0007606 | sensory perception of chemical stimulus(GO:0007606) |
| 0.0 | 4.3 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
| 0.0 | 0.4 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.0 | 0.7 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.0 | 0.1 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.0 | 0.1 | GO:1903984 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.0 | 0.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.0 | 0.2 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
| 0.0 | 0.3 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.0 | 0.2 | GO:0035308 | negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
| 0.0 | 0.2 | GO:0030183 | B cell differentiation(GO:0030183) |
| 0.0 | 0.4 | GO:0030518 | intracellular steroid hormone receptor signaling pathway(GO:0030518) |
| 0.0 | 0.2 | GO:0032801 | receptor catabolic process(GO:0032801) |
| 0.0 | 0.3 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.0 | 0.2 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
| 0.0 | 1.0 | GO:0043473 | pigmentation(GO:0043473) |
| 0.0 | 0.6 | GO:0019915 | lipid storage(GO:0019915) |
| 0.0 | 1.1 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
| 0.0 | 0.8 | GO:0071222 | cellular response to lipopolysaccharide(GO:0071222) |
| 0.0 | 0.7 | GO:0030316 | osteoclast differentiation(GO:0030316) |
| 0.0 | 1.1 | GO:0031032 | actomyosin structure organization(GO:0031032) |
| 0.0 | 0.4 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.0 | 1.4 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
| 0.0 | 0.2 | GO:0019321 | pentose metabolic process(GO:0019321) |
| 0.0 | 0.4 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
| 0.0 | 0.7 | GO:0007569 | cell aging(GO:0007569) |
| 0.0 | 0.1 | GO:1902475 | L-glutamate transmembrane transport(GO:0089711) L-alpha-amino acid transmembrane transport(GO:1902475) |
| 0.0 | 0.5 | GO:0006829 | zinc II ion transport(GO:0006829) |
| 0.0 | 0.3 | GO:0034394 | protein localization to cell surface(GO:0034394) |
| 0.0 | 0.3 | GO:0006298 | mismatch repair(GO:0006298) |
| 0.0 | 0.6 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
| 0.0 | 0.1 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
| 0.0 | 0.1 | GO:0072092 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
| 0.0 | 0.1 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.0 | 0.0 | GO:0032811 | negative regulation of norepinephrine secretion(GO:0010700) regulation of epinephrine secretion(GO:0014060) negative regulation of epinephrine secretion(GO:0032811) epinephrine transport(GO:0048241) epinephrine secretion(GO:0048242) |
| 0.0 | 0.1 | GO:0009644 | response to light intensity(GO:0009642) response to high light intensity(GO:0009644) |
| 0.0 | 0.2 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
| 0.0 | 0.2 | GO:0031167 | rRNA methylation(GO:0031167) |
| 0.0 | 0.3 | GO:0007520 | myoblast fusion(GO:0007520) |
| 0.0 | 0.3 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.0 | 0.2 | GO:0031507 | heterochromatin assembly(GO:0031507) |
| 0.0 | 0.1 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 0.0 | 0.3 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
| 0.0 | 0.0 | GO:0048302 | isotype switching to IgG isotypes(GO:0048291) regulation of isotype switching to IgG isotypes(GO:0048302) positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.0 | 0.2 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.0 | 0.1 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
| 0.0 | 0.2 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
| 0.0 | 0.1 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.1 | 65.9 | GO:0005614 | interstitial matrix(GO:0005614) |
| 3.2 | 9.5 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 3.1 | 9.2 | GO:0072534 | perineuronal net(GO:0072534) |
| 2.2 | 6.6 | GO:0098830 | presynaptic endosome(GO:0098830) |
| 2.2 | 6.6 | GO:1990257 | piccolo-bassoon transport vesicle(GO:1990257) |
| 2.0 | 8.2 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
| 1.6 | 9.4 | GO:0097443 | sorting endosome(GO:0097443) |
| 1.3 | 6.6 | GO:0044316 | cone cell pedicle(GO:0044316) |
| 1.3 | 7.6 | GO:0045179 | apical cortex(GO:0045179) |
| 1.1 | 15.0 | GO:0016342 | catenin complex(GO:0016342) |
| 1.1 | 1.1 | GO:0098888 | extrinsic component of presynaptic membrane(GO:0098888) |
| 1.0 | 6.0 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
| 1.0 | 25.5 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 0.9 | 28.4 | GO:0033268 | node of Ranvier(GO:0033268) |
| 0.9 | 2.7 | GO:0098831 | presynaptic active zone cytoplasmic component(GO:0098831) |
| 0.9 | 7.8 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.9 | 6.9 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
| 0.9 | 30.8 | GO:0090544 | BAF-type complex(GO:0090544) |
| 0.9 | 1.7 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 0.8 | 3.3 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
| 0.8 | 7.1 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.8 | 3.1 | GO:0097450 | astrocyte end-foot(GO:0097450) |
| 0.7 | 2.2 | GO:0044308 | axonal spine(GO:0044308) |
| 0.7 | 4.3 | GO:0071439 | clathrin complex(GO:0071439) |
| 0.7 | 7.7 | GO:0097449 | astrocyte projection(GO:0097449) |
| 0.7 | 3.4 | GO:1990037 | Lewy body core(GO:1990037) |
| 0.6 | 12.1 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
| 0.6 | 1.8 | GO:0098855 | HCN channel complex(GO:0098855) |
| 0.6 | 3.0 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.6 | 2.4 | GO:0031084 | BLOC-2 complex(GO:0031084) |
| 0.6 | 4.5 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.6 | 2.8 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 0.6 | 5.0 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
| 0.5 | 9.9 | GO:0032279 | asymmetric synapse(GO:0032279) |
| 0.5 | 4.4 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 0.5 | 2.7 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 0.5 | 5.4 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.5 | 2.1 | GO:0097441 | basilar dendrite(GO:0097441) |
| 0.5 | 5.5 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
| 0.5 | 2.5 | GO:0005726 | perichromatin fibrils(GO:0005726) |
| 0.5 | 1.5 | GO:0043512 | inhibin A complex(GO:0043512) |
| 0.5 | 1.5 | GO:0034657 | GID complex(GO:0034657) |
| 0.5 | 2.9 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
| 0.5 | 6.8 | GO:0043083 | synaptic cleft(GO:0043083) |
| 0.5 | 5.0 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
| 0.4 | 9.0 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.4 | 3.6 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.4 | 3.4 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 0.4 | 3.4 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
| 0.4 | 5.4 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.4 | 1.2 | GO:0016939 | kinesin II complex(GO:0016939) |
| 0.4 | 2.8 | GO:0005638 | lamin filament(GO:0005638) |
| 0.4 | 6.4 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.4 | 54.1 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
| 0.4 | 4.7 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.4 | 1.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
| 0.4 | 2.2 | GO:0000235 | astral microtubule(GO:0000235) |
| 0.4 | 1.5 | GO:0097447 | dendritic tree(GO:0097447) |
| 0.3 | 7.0 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
| 0.3 | 10.1 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 0.3 | 1.0 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
| 0.3 | 1.7 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.3 | 7.1 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
| 0.3 | 9.2 | GO:0030118 | clathrin coat(GO:0030118) |
| 0.3 | 6.2 | GO:0005682 | U5 snRNP(GO:0005682) |
| 0.3 | 5.9 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
| 0.3 | 1.5 | GO:0071986 | Ragulator complex(GO:0071986) |
| 0.2 | 0.7 | GO:0097233 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
| 0.2 | 1.0 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
| 0.2 | 6.8 | GO:0031430 | M band(GO:0031430) |
| 0.2 | 3.0 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.2 | 56.0 | GO:0045211 | postsynaptic membrane(GO:0045211) |
| 0.2 | 2.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 0.2 | 11.7 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.2 | 1.3 | GO:0097208 | alveolar lamellar body(GO:0097208) |
| 0.2 | 1.9 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.2 | 0.8 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
| 0.2 | 5.3 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
| 0.2 | 1.8 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 0.2 | 1.5 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.2 | 1.0 | GO:0033263 | CORVET complex(GO:0033263) |
| 0.2 | 2.5 | GO:0005605 | basal lamina(GO:0005605) |
| 0.2 | 1.7 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.2 | 33.0 | GO:0030427 | site of polarized growth(GO:0030427) |
| 0.2 | 2.1 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.2 | 2.4 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.2 | 5.7 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
| 0.2 | 2.6 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
| 0.2 | 1.3 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
| 0.2 | 22.7 | GO:0043197 | dendritic spine(GO:0043197) |
| 0.2 | 1.0 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
| 0.2 | 1.0 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
| 0.2 | 3.0 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.2 | 2.3 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 0.2 | 0.6 | GO:0032585 | multivesicular body membrane(GO:0032585) |
| 0.2 | 1.8 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.2 | 1.2 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
| 0.2 | 4.9 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.2 | 0.8 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.2 | 2.6 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.2 | 2.3 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.2 | 0.9 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
| 0.2 | 1.2 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
| 0.2 | 0.6 | GO:0070820 | tertiary granule(GO:0070820) |
| 0.1 | 0.6 | GO:0097386 | glial cell projection(GO:0097386) |
| 0.1 | 3.5 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 0.1 | 1.0 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.1 | 1.8 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 0.1 | 2.3 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 0.1 | 0.7 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.1 | 2.8 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.1 | 2.7 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.1 | 21.3 | GO:0001650 | fibrillar center(GO:0001650) |
| 0.1 | 0.4 | GO:1903095 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
| 0.1 | 0.4 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 0.1 | 1.4 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
| 0.1 | 0.7 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 0.1 | 3.7 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.1 | 0.4 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
| 0.1 | 0.3 | GO:0071953 | elastic fiber(GO:0071953) |
| 0.1 | 1.4 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.1 | 2.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.1 | 1.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 0.1 | 1.0 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
| 0.1 | 16.5 | GO:0030027 | lamellipodium(GO:0030027) |
| 0.1 | 1.0 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.1 | 3.5 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.1 | 0.7 | GO:0005955 | calcineurin complex(GO:0005955) |
| 0.1 | 2.3 | GO:0097228 | sperm principal piece(GO:0097228) |
| 0.1 | 0.5 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 0.1 | 1.8 | GO:0005771 | multivesicular body(GO:0005771) |
| 0.1 | 4.6 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.1 | 0.3 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 0.1 | 6.8 | GO:0005770 | late endosome(GO:0005770) |
| 0.1 | 0.7 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 0.1 | 1.3 | GO:0030126 | COPI vesicle coat(GO:0030126) |
| 0.1 | 0.3 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
| 0.1 | 0.4 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
| 0.1 | 1.1 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.1 | 2.2 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
| 0.1 | 1.8 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 0.1 | 1.0 | GO:0044754 | secondary lysosome(GO:0005767) autolysosome(GO:0044754) |
| 0.1 | 8.1 | GO:0055037 | recycling endosome(GO:0055037) |
| 0.1 | 0.8 | GO:0097542 | ciliary tip(GO:0097542) |
| 0.1 | 0.6 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.1 | 1.2 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.1 | 8.5 | GO:0070382 | exocytic vesicle(GO:0070382) |
| 0.1 | 10.6 | GO:0005802 | trans-Golgi network(GO:0005802) |
| 0.1 | 7.0 | GO:0044306 | neuron projection terminus(GO:0044306) |
| 0.1 | 7.4 | GO:0016605 | PML body(GO:0016605) |
| 0.1 | 0.5 | GO:0098536 | deuterosome(GO:0098536) |
| 0.1 | 6.3 | GO:0005814 | centriole(GO:0005814) |
| 0.1 | 1.3 | GO:0000145 | exocyst(GO:0000145) |
| 0.1 | 0.8 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.1 | 0.2 | GO:0048179 | activin receptor complex(GO:0048179) |
| 0.1 | 0.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.1 | 0.7 | GO:0000439 | core TFIIH complex(GO:0000439) |
| 0.1 | 1.2 | GO:0031201 | SNARE complex(GO:0031201) |
| 0.1 | 0.5 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
| 0.1 | 1.4 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
| 0.1 | 2.5 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
| 0.1 | 1.0 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.1 | 0.5 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.1 | 10.9 | GO:0030424 | axon(GO:0030424) |
| 0.1 | 1.1 | GO:0030315 | T-tubule(GO:0030315) |
| 0.1 | 0.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.1 | 0.8 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.1 | 0.9 | GO:0030659 | cytoplasmic vesicle membrane(GO:0030659) |
| 0.1 | 1.2 | GO:0005921 | gap junction(GO:0005921) |
| 0.1 | 2.9 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
| 0.1 | 0.8 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) COPII vesicle coat(GO:0030127) |
| 0.0 | 1.0 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
| 0.0 | 2.3 | GO:0043204 | perikaryon(GO:0043204) |
| 0.0 | 6.7 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
| 0.0 | 2.3 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.0 | 0.4 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.0 | 0.9 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 0.0 | 0.7 | GO:0098562 | cytoplasmic side of membrane(GO:0098562) |
| 0.0 | 0.4 | GO:0030057 | desmosome(GO:0030057) |
| 0.0 | 0.5 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.0 | 1.8 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.0 | 0.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.0 | 0.5 | GO:0002102 | podosome(GO:0002102) |
| 0.0 | 0.6 | GO:0032039 | integrator complex(GO:0032039) |
| 0.0 | 0.3 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
| 0.0 | 0.3 | GO:0016460 | myosin II complex(GO:0016460) |
| 0.0 | 0.2 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.0 | 0.2 | GO:0030897 | HOPS complex(GO:0030897) |
| 0.0 | 1.0 | GO:0005776 | autophagosome(GO:0005776) |
| 0.0 | 1.2 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.0 | 0.8 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
| 0.0 | 0.6 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.0 | 0.6 | GO:0035861 | site of double-strand break(GO:0035861) |
| 0.0 | 0.1 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 0.0 | 1.0 | GO:0005923 | bicellular tight junction(GO:0005923) |
| 0.0 | 0.3 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.0 | 1.7 | GO:0005769 | early endosome(GO:0005769) |
| 0.0 | 0.6 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.0 | 0.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
| 0.0 | 57.7 | GO:0016021 | integral component of membrane(GO:0016021) |
| 0.0 | 0.1 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
| 0.0 | 0.4 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
| 0.0 | 0.1 | GO:0061574 | ASAP complex(GO:0061574) |
| 0.0 | 0.1 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
| 0.0 | 1.9 | GO:0005768 | endosome(GO:0005768) |
| 0.0 | 1.2 | GO:0034399 | nuclear periphery(GO:0034399) |
| 0.0 | 0.8 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.0 | 0.1 | GO:0001940 | female pronucleus(GO:0001939) male pronucleus(GO:0001940) |
| 0.0 | 0.1 | GO:0002177 | manchette(GO:0002177) |
| 0.0 | 0.2 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.8 | 22.7 | GO:0045545 | syndecan binding(GO:0045545) |
| 2.9 | 14.4 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
| 2.7 | 8.2 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) |
| 2.7 | 16.1 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 2.5 | 7.6 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
| 2.0 | 8.0 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 1.9 | 5.7 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
| 1.7 | 6.8 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 1.6 | 4.8 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
| 1.6 | 11.2 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 1.4 | 4.3 | GO:0016160 | alpha-amylase activity(GO:0004556) amylase activity(GO:0016160) |
| 1.4 | 4.2 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
| 1.3 | 50.0 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 1.2 | 4.9 | GO:0030151 | molybdenum ion binding(GO:0030151) |
| 1.2 | 6.1 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
| 1.2 | 8.4 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
| 1.1 | 4.6 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
| 1.1 | 3.4 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 1.1 | 3.3 | GO:0002153 | steroid receptor RNA activator RNA binding(GO:0002153) |
| 1.1 | 4.5 | GO:0038025 | reelin receptor activity(GO:0038025) |
| 1.1 | 9.8 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
| 1.1 | 3.2 | GO:0070890 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
| 1.1 | 43.7 | GO:0030552 | cAMP binding(GO:0030552) |
| 1.1 | 7.5 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 1.0 | 5.1 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
| 1.0 | 12.2 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 1.0 | 5.9 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 1.0 | 2.9 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 1.0 | 6.8 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 0.9 | 2.7 | GO:0015228 | coenzyme A transmembrane transporter activity(GO:0015228) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
| 0.9 | 3.5 | GO:0031687 | A2A adenosine receptor binding(GO:0031687) |
| 0.9 | 3.4 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
| 0.8 | 3.3 | GO:0031720 | haptoglobin binding(GO:0031720) |
| 0.8 | 2.5 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
| 0.8 | 2.4 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
| 0.8 | 8.8 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
| 0.8 | 2.3 | GO:0001160 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
| 0.8 | 2.3 | GO:0008527 | taste receptor activity(GO:0008527) |
| 0.8 | 5.3 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
| 0.8 | 3.0 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
| 0.8 | 2.3 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 0.7 | 4.4 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.7 | 5.0 | GO:0099609 | microtubule lateral binding(GO:0099609) |
| 0.7 | 5.7 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
| 0.7 | 2.8 | GO:0004104 | cholinesterase activity(GO:0004104) choline binding(GO:0033265) |
| 0.7 | 4.2 | GO:0070699 | type II activin receptor binding(GO:0070699) |
| 0.7 | 7.0 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
| 0.7 | 4.0 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
| 0.7 | 14.5 | GO:0071949 | FAD binding(GO:0071949) |
| 0.6 | 2.6 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 0.6 | 15.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.6 | 1.8 | GO:0043758 | acetate-CoA ligase (ADP-forming) activity(GO:0043758) |
| 0.6 | 6.5 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
| 0.6 | 1.8 | GO:0005119 | smoothened binding(GO:0005119) hedgehog receptor activity(GO:0008158) |
| 0.6 | 8.2 | GO:0035198 | miRNA binding(GO:0035198) |
| 0.6 | 1.7 | GO:0003692 | left-handed Z-DNA binding(GO:0003692) |
| 0.6 | 2.8 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
| 0.6 | 2.8 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups(GO:0016725) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 0.6 | 3.3 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
| 0.5 | 3.3 | GO:0089720 | caspase binding(GO:0089720) |
| 0.5 | 2.2 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 0.5 | 2.2 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
| 0.5 | 4.8 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.5 | 7.5 | GO:0031005 | filamin binding(GO:0031005) |
| 0.5 | 3.7 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
| 0.5 | 1.1 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.5 | 2.1 | GO:0051378 | serotonin binding(GO:0051378) |
| 0.5 | 1.6 | GO:0019120 | hydrolase activity, acting on acid halide bonds(GO:0016824) hydrolase activity, acting on acid halide bonds, in C-halide compounds(GO:0019120) alkylhalidase activity(GO:0047651) |
| 0.5 | 3.6 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 0.5 | 8.6 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.5 | 2.0 | GO:0034481 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) chondroitin sulfotransferase activity(GO:0034481) |
| 0.5 | 2.0 | GO:0070012 | oligopeptidase activity(GO:0070012) |
| 0.5 | 1.5 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
| 0.5 | 2.4 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 0.5 | 1.9 | GO:0004441 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) |
| 0.5 | 2.3 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 0.5 | 7.8 | GO:0046625 | sphingolipid binding(GO:0046625) |
| 0.5 | 10.5 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
| 0.5 | 1.4 | GO:0016748 | succinyltransferase activity(GO:0016748) |
| 0.4 | 1.3 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
| 0.4 | 4.9 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.4 | 4.4 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.4 | 1.3 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.4 | 2.6 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.4 | 1.7 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.4 | 0.4 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
| 0.4 | 1.2 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 0.4 | 10.1 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 0.4 | 3.6 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.4 | 1.2 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
| 0.4 | 4.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.4 | 20.3 | GO:0036002 | pre-mRNA binding(GO:0036002) |
| 0.4 | 2.6 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
| 0.4 | 1.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.4 | 1.5 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
| 0.4 | 1.8 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
| 0.4 | 3.9 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.4 | 20.5 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.3 | 1.4 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.3 | 5.4 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
| 0.3 | 1.4 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
| 0.3 | 3.3 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 0.3 | 2.0 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 0.3 | 5.0 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
| 0.3 | 1.6 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.3 | 39.1 | GO:0008201 | heparin binding(GO:0008201) |
| 0.3 | 3.9 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
| 0.3 | 0.6 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
| 0.3 | 1.3 | GO:0019863 | IgE binding(GO:0019863) |
| 0.3 | 3.2 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.3 | 0.9 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
| 0.3 | 1.9 | GO:0004984 | olfactory receptor activity(GO:0004984) |
| 0.3 | 2.5 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
| 0.3 | 0.9 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
| 0.3 | 6.8 | GO:0043394 | proteoglycan binding(GO:0043394) |
| 0.3 | 9.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.3 | 18.1 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
| 0.3 | 0.9 | GO:0046997 | sarcosine dehydrogenase activity(GO:0008480) oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
| 0.3 | 4.5 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
| 0.3 | 1.8 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
| 0.3 | 1.5 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.3 | 4.8 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.3 | 1.2 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
| 0.3 | 6.8 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
| 0.3 | 1.2 | GO:0050347 | trans-hexaprenyltranstransferase activity(GO:0000010) trans-octaprenyltranstransferase activity(GO:0050347) |
| 0.3 | 1.7 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
| 0.3 | 1.4 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
| 0.3 | 19.5 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
| 0.3 | 3.0 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.3 | 1.4 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
| 0.3 | 2.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 0.3 | 0.8 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
| 0.3 | 1.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 0.3 | 2.4 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
| 0.3 | 6.2 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.3 | 1.1 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
| 0.3 | 7.9 | GO:0051018 | protein kinase A binding(GO:0051018) |
| 0.3 | 2.0 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
| 0.3 | 0.8 | GO:0004473 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
| 0.3 | 6.9 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.3 | 1.0 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.3 | 9.8 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
| 0.2 | 1.5 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 0.2 | 5.2 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.2 | 3.4 | GO:0043495 | protein anchor(GO:0043495) |
| 0.2 | 0.7 | GO:0004998 | transferrin receptor activity(GO:0004998) |
| 0.2 | 4.6 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
| 0.2 | 2.9 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.2 | 3.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.2 | 4.3 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.2 | 4.8 | GO:0031402 | sodium ion binding(GO:0031402) |
| 0.2 | 0.7 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.2 | 5.1 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.2 | 0.7 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.2 | 1.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
| 0.2 | 1.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
| 0.2 | 0.7 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
| 0.2 | 27.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.2 | 2.5 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.2 | 1.5 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.2 | 1.3 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
| 0.2 | 0.6 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.2 | 0.6 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.2 | 1.3 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.2 | 3.1 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.2 | 32.3 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.2 | 1.0 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
| 0.2 | 0.6 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 0.2 | 9.9 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.2 | 1.0 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.2 | 0.6 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
| 0.2 | 0.6 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
| 0.2 | 1.2 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.2 | 2.1 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
| 0.2 | 1.1 | GO:0070728 | leucine binding(GO:0070728) |
| 0.2 | 0.6 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.2 | 1.6 | GO:0071253 | connexin binding(GO:0071253) |
| 0.2 | 1.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.2 | 6.2 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
| 0.2 | 2.8 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 0.2 | 1.6 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.2 | 3.9 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.2 | 0.5 | GO:0004980 | melanocortin receptor activity(GO:0004977) melanocyte-stimulating hormone receptor activity(GO:0004980) |
| 0.2 | 0.9 | GO:0008761 | UDP-N-acetylglucosamine 2-epimerase activity(GO:0008761) N-acylmannosamine kinase activity(GO:0009384) |
| 0.2 | 2.5 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
| 0.2 | 0.5 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
| 0.2 | 3.8 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.2 | 1.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.2 | 33.4 | GO:0003714 | transcription corepressor activity(GO:0003714) |
| 0.2 | 5.9 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
| 0.2 | 6.7 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.2 | 1.4 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.2 | 4.7 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.2 | 1.9 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
| 0.2 | 0.5 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
| 0.2 | 3.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.2 | 0.9 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
| 0.2 | 0.3 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.2 | 0.8 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.2 | 1.7 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.2 | 2.4 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
| 0.2 | 0.2 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
| 0.1 | 1.6 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
| 0.1 | 1.9 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.1 | 1.0 | GO:0030911 | TPR domain binding(GO:0030911) |
| 0.1 | 0.9 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
| 0.1 | 0.4 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 0.1 | 3.0 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
| 0.1 | 1.3 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
| 0.1 | 0.4 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 0.1 | 1.9 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
| 0.1 | 0.8 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
| 0.1 | 5.6 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
| 0.1 | 1.5 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.1 | 0.9 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.1 | 2.4 | GO:0070840 | dynein complex binding(GO:0070840) |
| 0.1 | 1.7 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.1 | 0.6 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
| 0.1 | 1.0 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
| 0.1 | 2.1 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
| 0.1 | 0.6 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 0.1 | 0.5 | GO:0031685 | adenosine receptor binding(GO:0031685) |
| 0.1 | 3.4 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.1 | 4.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.1 | 0.6 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
| 0.1 | 2.6 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
| 0.1 | 0.9 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
| 0.1 | 0.5 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
| 0.1 | 1.0 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
| 0.1 | 3.9 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
| 0.1 | 0.2 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
| 0.1 | 0.7 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
| 0.1 | 1.1 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
| 0.1 | 0.6 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 0.1 | 1.1 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.1 | 0.4 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
| 0.1 | 2.1 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
| 0.1 | 3.0 | GO:0016247 | channel regulator activity(GO:0016247) |
| 0.1 | 1.7 | GO:0032452 | histone demethylase activity(GO:0032452) |
| 0.1 | 2.2 | GO:0042287 | MHC protein binding(GO:0042287) |
| 0.1 | 0.5 | GO:0070330 | aromatase activity(GO:0070330) |
| 0.1 | 0.6 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.1 | 0.6 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 0.1 | 0.6 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 0.1 | 7.9 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
| 0.1 | 1.9 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
| 0.1 | 0.3 | GO:0035591 | signaling adaptor activity(GO:0035591) |
| 0.1 | 1.3 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
| 0.1 | 0.2 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
| 0.1 | 0.4 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
| 0.1 | 0.9 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
| 0.1 | 0.6 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
| 0.1 | 8.8 | GO:0005516 | calmodulin binding(GO:0005516) |
| 0.1 | 7.3 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) ATPase activity, coupled to movement of substances(GO:0043492) |
| 0.1 | 2.2 | GO:0008374 | O-acyltransferase activity(GO:0008374) |
| 0.1 | 1.0 | GO:0019531 | secondary active sulfate transmembrane transporter activity(GO:0008271) oxalate transmembrane transporter activity(GO:0019531) |
| 0.1 | 1.7 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.1 | 0.8 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
| 0.1 | 1.8 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
| 0.1 | 2.2 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.1 | 11.3 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.1 | 0.3 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) N-acetyllactosamine synthase activity(GO:0003945) |
| 0.1 | 1.0 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.1 | 2.9 | GO:0008146 | sulfotransferase activity(GO:0008146) |
| 0.1 | 3.7 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
| 0.1 | 3.8 | GO:0005080 | protein kinase C binding(GO:0005080) |
| 0.1 | 0.5 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
| 0.1 | 1.7 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.1 | 5.9 | GO:0030165 | PDZ domain binding(GO:0030165) |
| 0.1 | 2.5 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.1 | 0.7 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
| 0.1 | 0.2 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
| 0.1 | 0.5 | GO:0005522 | profilin binding(GO:0005522) |
| 0.1 | 2.2 | GO:0019213 | deacetylase activity(GO:0019213) |
| 0.1 | 0.4 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.1 | 0.7 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.1 | 0.4 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.1 | 0.4 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
| 0.1 | 0.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.1 | 0.8 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
| 0.1 | 0.3 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 0.1 | 2.2 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.1 | 0.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 0.1 | 1.5 | GO:0017147 | Wnt-protein binding(GO:0017147) |
| 0.1 | 0.8 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
| 0.1 | 0.5 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
| 0.1 | 0.3 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
| 0.1 | 1.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.1 | 0.2 | GO:0004510 | tryptophan 5-monooxygenase activity(GO:0004510) |
| 0.1 | 0.9 | GO:0005537 | mannose binding(GO:0005537) |
| 0.1 | 0.2 | GO:0016361 | activin receptor activity, type I(GO:0016361) activin-activated receptor activity(GO:0017002) |
| 0.1 | 1.2 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.1 | 1.9 | GO:0005262 | calcium channel activity(GO:0005262) |
| 0.1 | 0.3 | GO:0030983 | mismatched DNA binding(GO:0030983) |
| 0.1 | 2.7 | GO:0017048 | Rho GTPase binding(GO:0017048) |
| 0.1 | 0.3 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
| 0.1 | 0.8 | GO:0017046 | peptide hormone binding(GO:0017046) |
| 0.0 | 0.4 | GO:0015149 | glucose transmembrane transporter activity(GO:0005355) monosaccharide transmembrane transporter activity(GO:0015145) hexose transmembrane transporter activity(GO:0015149) |
| 0.0 | 0.5 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.0 | 0.3 | GO:0048018 | receptor agonist activity(GO:0048018) |
| 0.0 | 3.7 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
| 0.0 | 1.1 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
| 0.0 | 4.5 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
| 0.0 | 0.3 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.0 | 0.5 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
| 0.0 | 0.2 | GO:0015086 | cadmium ion transmembrane transporter activity(GO:0015086) lead ion transmembrane transporter activity(GO:0015094) vanadium ion transmembrane transporter activity(GO:0015100) ferrous iron uptake transmembrane transporter activity(GO:0015639) cadmium ion binding(GO:0046870) |
| 0.0 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
| 0.0 | 6.6 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.0 | 0.7 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.0 | 1.3 | GO:0043621 | protein self-association(GO:0043621) |
| 0.0 | 1.1 | GO:0017022 | myosin binding(GO:0017022) |
| 0.0 | 0.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.0 | 1.9 | GO:0004540 | ribonuclease activity(GO:0004540) |
| 0.0 | 0.6 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.0 | 1.4 | GO:0030674 | protein binding, bridging(GO:0030674) |
| 0.0 | 0.6 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 0.0 | 0.4 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
| 0.0 | 5.9 | GO:0008017 | microtubule binding(GO:0008017) |
| 0.0 | 0.9 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.0 | 0.7 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
| 0.0 | 0.2 | GO:0043141 | 5'-3' DNA helicase activity(GO:0043139) ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
| 0.0 | 0.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.0 | 0.5 | GO:0051117 | ATPase binding(GO:0051117) |
| 0.0 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
| 0.0 | 0.2 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
| 0.0 | 0.2 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.0 | 11.9 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
| 0.0 | 0.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.0 | 0.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.0 | 0.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 0.0 | 0.1 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
| 0.0 | 0.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.0 | 0.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.0 | 0.0 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.0 | 0.6 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.0 | 0.3 | GO:0015929 | hexosaminidase activity(GO:0015929) |
| 0.0 | 1.1 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
| 0.0 | 0.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
| 0.0 | 0.6 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.0 | 0.2 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
| 0.0 | 0.4 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.0 | 0.2 | GO:0005521 | lamin binding(GO:0005521) |
| 0.0 | 0.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.0 | 0.3 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
| 0.0 | 0.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
| 0.0 | 0.3 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.0 | 0.1 | GO:0030619 | U1 snRNA binding(GO:0030619) |
| 0.0 | 0.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.0 | 0.4 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
| 0.0 | 0.1 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.9 | 24.4 | PID_INTEGRIN_A9B1_PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.8 | 5.7 | PID_VEGFR1_2_PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.7 | 3.6 | PID_PDGFRA_PATHWAY | PDGFR-alpha signaling pathway |
| 0.4 | 21.6 | PID_CDC42_REG_PATHWAY | Regulation of CDC42 activity |
| 0.4 | 21.4 | PID_REELIN_PATHWAY | Reelin signaling pathway |
| 0.4 | 25.2 | PID_ERBB1_INTERNALIZATION_PATHWAY | Internalization of ErbB1 |
| 0.4 | 9.6 | PID_MAPK_TRK_PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.4 | 10.4 | PID_ARF_3PATHWAY | Arf1 pathway |
| 0.3 | 12.7 | SIG_CHEMOTAXIS | Genes related to chemotaxis |
| 0.3 | 8.2 | PID_LIS1_PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.3 | 9.9 | PID_INSULIN_GLUCOSE_PATHWAY | Insulin-mediated glucose transport |
| 0.3 | 2.5 | PID_VEGF_VEGFR_PATHWAY | VEGF and VEGFR signaling network |
| 0.3 | 34.1 | PID_PDGFRB_PATHWAY | PDGFR-beta signaling pathway |
| 0.3 | 3.9 | ST_G_ALPHA_S_PATHWAY | G alpha s Pathway |
| 0.3 | 12.5 | PID_HNF3A_PATHWAY | FOXA1 transcription factor network |
| 0.2 | 6.3 | PID_NFKAPPAB_CANONICAL_PATHWAY | Canonical NF-kappaB pathway |
| 0.2 | 5.8 | PID_HDAC_CLASSIII_PATHWAY | Signaling events mediated by HDAC Class III |
| 0.2 | 11.1 | PID_TAP63_PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.2 | 1.1 | PID_EPHA2_FWD_PATHWAY | EPHA2 forward signaling |
| 0.2 | 1.5 | SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.2 | 4.8 | PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.2 | 4.1 | PID_DNA_PK_PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.2 | 3.9 | ST_JNK_MAPK_PATHWAY | JNK MAPK Pathway |
| 0.2 | 4.6 | PID_BCR_5PATHWAY | BCR signaling pathway |
| 0.2 | 1.9 | PID_ECADHERIN_KERATINOCYTE_PATHWAY | E-cadherin signaling in keratinocytes |
| 0.2 | 4.1 | PID_RXR_VDR_PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.1 | 1.0 | PID_ARF6_DOWNSTREAM_PATHWAY | Arf6 downstream pathway |
| 0.1 | 1.1 | PID_GMCSF_PATHWAY | GMCSF-mediated signaling events |
| 0.1 | 3.4 | PID_PI3KCI_PATHWAY | Class I PI3K signaling events |
| 0.1 | 6.4 | PID_RHOA_REG_PATHWAY | Regulation of RhoA activity |
| 0.1 | 3.6 | PID_INTEGRIN_A4B1_PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.1 | 0.6 | PID_THROMBIN_PAR4_PATHWAY | PAR4-mediated thrombin signaling events |
| 0.1 | 2.1 | PID_ERBB2_ERBB3_PATHWAY | ErbB2/ErbB3 signaling events |
| 0.1 | 2.9 | PID_RAC1_REG_PATHWAY | Regulation of RAC1 activity |
| 0.1 | 7.1 | PID_AR_TF_PATHWAY | Regulation of Androgen receptor activity |
| 0.1 | 4.2 | PID_HDAC_CLASSII_PATHWAY | Signaling events mediated by HDAC Class II |
| 0.1 | 3.5 | PID_CERAMIDE_PATHWAY | Ceramide signaling pathway |
| 0.1 | 0.1 | PID_IL5_PATHWAY | IL5-mediated signaling events |
| 0.1 | 11.8 | NABA_ECM_AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.1 | 1.2 | PID_P38_MKK3_6PATHWAY | p38 MAPK signaling pathway |
| 0.1 | 1.8 | PID_HEDGEHOG_2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.1 | 1.4 | SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES | Genes related to the insulin receptor pathway |
| 0.1 | 2.1 | PID_BETA_CATENIN_DEG_PATHWAY | Degradation of beta catenin |
| 0.1 | 1.1 | ST_ERK1_ERK2_MAPK_PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.1 | 1.5 | PID_NETRIN_PATHWAY | Netrin-mediated signaling events |
| 0.1 | 2.5 | NABA_PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.1 | 1.5 | PID_ARF6_PATHWAY | Arf6 signaling events |
| 0.1 | 0.1 | PID_TCR_JNK_PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 0.1 | 2.3 | PID_LKB1_PATHWAY | LKB1 signaling events |
| 0.1 | 0.7 | PID_ECADHERIN_NASCENT_AJ_PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.1 | 0.9 | PID_MET_PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.1 | 9.0 | NABA_SECRETED_FACTORS | Genes encoding secreted soluble factors |
| 0.0 | 0.6 | PID_LPA4_PATHWAY | LPA4-mediated signaling events |
| 0.0 | 0.9 | PID_KIT_PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.0 | 0.2 | PID_EPHB_FWD_PATHWAY | EPHB forward signaling |
| 0.0 | 0.2 | PID_WNT_CANONICAL_PATHWAY | Canonical Wnt signaling pathway |
| 0.0 | 1.0 | PID_IL6_7_PATHWAY | IL6-mediated signaling events |
| 0.0 | 0.6 | PID_TOLL_ENDOGENOUS_PATHWAY | Endogenous TLR signaling |
| 0.0 | 0.8 | PID_ECADHERIN_STABILIZATION_PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.0 | 0.1 | PID_P38_GAMMA_DELTA_PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.0 | 0.5 | PID_RHOA_PATHWAY | RhoA signaling pathway |
| 0.0 | 0.2 | PID_IL8_CXCR2_PATHWAY | IL8- and CXCR2-mediated signaling events |
| 0.0 | 0.4 | PID_ANGIOPOIETIN_RECEPTOR_PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.0 | 0.7 | PID_INTEGRIN3_PATHWAY | Beta3 integrin cell surface interactions |
| 0.0 | 3.3 | NABA_ECM_GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.0 | 1.4 | PID_HIF1_TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.0 | 0.2 | PID_SYNDECAN_2_PATHWAY | Syndecan-2-mediated signaling events |
| 0.0 | 0.1 | PID_RHODOPSIN_PATHWAY | Visual signal transduction: Rods |
| 0.0 | 0.3 | PID_ERBB4_PATHWAY | ErbB4 signaling events |
| 0.0 | 0.1 | ST_MYOCYTE_AD_PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.0 | 0.2 | PID_HIF2PATHWAY | HIF-2-alpha transcription factor network |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.4 | 1.4 | REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING | Genes involved in SHC1 events in EGFR signaling |
| 0.8 | 36.1 | REACTOME_DARPP_32_EVENTS | Genes involved in DARPP-32 events |
| 0.7 | 6.0 | REACTOME_GAP_JUNCTION_DEGRADATION | Genes involved in Gap junction degradation |
| 0.6 | 22.1 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.6 | 8.5 | REACTOME_CTNNB1_PHOSPHORYLATION_CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.6 | 4.1 | REACTOME_ARMS_MEDIATED_ACTIVATION | Genes involved in ARMS-mediated activation |
| 0.5 | 7.7 | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.5 | 1.6 | REACTOME_TRANSLOCATION_OF_ZAP_70_TO_IMMUNOLOGICAL_SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
| 0.5 | 6.5 | REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.5 | 9.2 | REACTOME_LIGAND_GATED_ION_CHANNEL_TRANSPORT | Genes involved in Ligand-gated ion channel transport |
| 0.5 | 4.8 | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 0.5 | 7.5 | REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING | Genes involved in DCC mediated attractive signaling |
| 0.5 | 7.0 | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.5 | 5.6 | REACTOME_RAP1_SIGNALLING | Genes involved in Rap1 signalling |
| 0.5 | 15.0 | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.4 | 4.2 | REACTOME_NEPHRIN_INTERACTIONS | Genes involved in Nephrin interactions |
| 0.4 | 17.4 | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.4 | 2.0 | REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
| 0.4 | 7.8 | REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 0.4 | 8.9 | REACTOME_RAS_ACTIVATION_UOPN_CA2_INFUX_THROUGH_NMDA_RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 0.4 | 14.0 | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.4 | 1.5 | REACTOME_GLYCOPROTEIN_HORMONES | Genes involved in Glycoprotein hormones |
| 0.4 | 11.7 | REACTOME_MYOGENESIS | Genes involved in Myogenesis |
| 0.3 | 11.5 | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.3 | 4.5 | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.3 | 6.3 | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION | Genes involved in N-Glycan antennae elongation |
| 0.3 | 7.9 | REACTOME_SYNTHESIS_OF_PC | Genes involved in Synthesis of PC |
| 0.3 | 8.9 | REACTOME_RNA_POL_III_TRANSCRIPTION_TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
| 0.3 | 3.8 | REACTOME_COPI_MEDIATED_TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.3 | 1.6 | REACTOME_PLATELET_SENSITIZATION_BY_LDL | Genes involved in Platelet sensitization by LDL |
| 0.3 | 23.4 | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | Genes involved in NRAGE signals death through JNK |
| 0.3 | 28.8 | REACTOME_L1CAM_INTERACTIONS | Genes involved in L1CAM interactions |
| 0.3 | 4.1 | REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.3 | 2.3 | REACTOME_AMYLOIDS | Genes involved in Amyloids |
| 0.3 | 2.3 | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.3 | 2.5 | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
| 0.3 | 18.4 | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.3 | 3.6 | REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE | Genes involved in GPVI-mediated activation cascade |
| 0.3 | 0.3 | REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
| 0.3 | 10.7 | REACTOME_INHIBITION_OF_VOLTAGE_GATED_CA2_CHANNELS_VIA_GBETA_GAMMA_SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
| 0.3 | 6.8 | REACTOME_NOD1_2_SIGNALING_PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
| 0.3 | 2.3 | REACTOME_BILE_SALT_AND_ORGANIC_ANION_SLC_TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.3 | 5.6 | REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.2 | 5.1 | REACTOME_INSULIN_RECEPTOR_RECYCLING | Genes involved in Insulin receptor recycling |
| 0.2 | 7.7 | REACTOME_SIGNALING_BY_ROBO_RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.2 | 2.5 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.2 | 5.2 | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.2 | 0.6 | REACTOME_ADP_SIGNALLING_THROUGH_P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
| 0.2 | 1.2 | REACTOME_IL_6_SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.2 | 1.0 | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
| 0.2 | 1.4 | REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
| 0.2 | 5.5 | REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.2 | 1.9 | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | Genes involved in PKA-mediated phosphorylation of CREB |
| 0.2 | 1.2 | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.2 | 1.5 | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.2 | 6.4 | REACTOME_GLYCOLYSIS | Genes involved in Glycolysis |
| 0.2 | 3.5 | REACTOME_ALPHA_LINOLENIC_ACID_ALA_METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.2 | 6.0 | REACTOME_HS_GAG_BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.2 | 1.3 | REACTOME_IL_RECEPTOR_SHC_SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.2 | 4.3 | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.2 | 5.8 | REACTOME_NUCLEAR_SIGNALING_BY_ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
| 0.2 | 3.4 | REACTOME_OTHER_SEMAPHORIN_INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.2 | 1.2 | REACTOME_MEMBRANE_BINDING_AND_TARGETTING_OF_GAG_PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.1 | 3.6 | REACTOME_CGMP_EFFECTS | Genes involved in cGMP effects |
| 0.1 | 12.4 | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | Genes involved in Transmission across Chemical Synapses |
| 0.1 | 1.4 | REACTOME_PROTEOLYTIC_CLEAVAGE_OF_SNARE_COMPLEX_PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.1 | 4.4 | REACTOME_SYNTHESIS_OF_PA | Genes involved in Synthesis of PA |
| 0.1 | 4.9 | REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
| 0.1 | 5.3 | REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.1 | 1.8 | REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.1 | 1.6 | REACTOME_IL1_SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.1 | 2.5 | REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.1 | 1.8 | REACTOME_POTASSIUM_CHANNELS | Genes involved in Potassium Channels |
| 0.1 | 1.8 | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.1 | 2.1 | REACTOME_PIP3_ACTIVATES_AKT_SIGNALING | Genes involved in PIP3 activates AKT signaling |
| 0.1 | 0.5 | REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
| 0.1 | 1.9 | REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION | Genes involved in Downstream signal transduction |
| 0.1 | 2.0 | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
| 0.1 | 0.3 | REACTOME_FORMATION_OF_TRANSCRIPTION_COUPLED_NER_TC_NER_REPAIR_COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
| 0.1 | 0.8 | REACTOME_CIRCADIAN_REPRESSION_OF_EXPRESSION_BY_REV_ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
| 0.1 | 0.4 | REACTOME_ENOS_ACTIVATION_AND_REGULATION | Genes involved in eNOS activation and regulation |
| 0.1 | 0.6 | REACTOME_ROLE_OF_DCC_IN_REGULATING_APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.1 | 2.6 | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.1 | 0.5 | REACTOME_TIE2_SIGNALING | Genes involved in Tie2 Signaling |
| 0.1 | 0.2 | REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING | Genes involved in PI3K events in ERBB2 signaling |
| 0.1 | 5.9 | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.1 | 0.5 | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 0.1 | 0.6 | REACTOME_TRYPTOPHAN_CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.1 | 1.0 | REACTOME_PURINE_SALVAGE | Genes involved in Purine salvage |
| 0.1 | 0.9 | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
| 0.1 | 2.9 | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.1 | 1.8 | REACTOME_SIGNALING_BY_EGFR_IN_CANCER | Genes involved in Signaling by EGFR in Cancer |
| 0.1 | 2.1 | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.1 | 0.3 | REACTOME_SIGNALING_BY_NOTCH4 | Genes involved in Signaling by NOTCH4 |
| 0.1 | 1.0 | REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.1 | 0.5 | REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
| 0.0 | 0.6 | REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION | Genes involved in Platelet activation, signaling and aggregation |
| 0.0 | 1.9 | REACTOME_GLUCOSE_TRANSPORT | Genes involved in Glucose transport |
| 0.0 | 4.4 | REACTOME_SIGNALING_BY_RHO_GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.0 | 0.4 | REACTOME_PASSIVE_TRANSPORT_BY_AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.0 | 1.1 | REACTOME_METAL_ION_SLC_TRANSPORTERS | Genes involved in Metal ion SLC transporters |
| 0.0 | 1.0 | REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.0 | 0.7 | REACTOME_METABOLISM_OF_STEROID_HORMONES_AND_VITAMINS_A_AND_D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
| 0.0 | 1.2 | REACTOME_SPHINGOLIPID_METABOLISM | Genes involved in Sphingolipid metabolism |
| 0.0 | 1.0 | REACTOME_PERK_REGULATED_GENE_EXPRESSION | Genes involved in PERK regulated gene expression |
| 0.0 | 0.9 | REACTOME_DOUBLE_STRAND_BREAK_REPAIR | Genes involved in Double-Strand Break Repair |
| 0.0 | 0.2 | REACTOME_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
| 0.0 | 0.9 | REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER | Genes involved in Formation of incision complex in GG-NER |
| 0.0 | 0.2 | REACTOME_SIGNALING_BY_NODAL | Genes involved in Signaling by NODAL |
| 0.0 | 0.3 | REACTOME_REGULATION_OF_KIT_SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.0 | 0.4 | REACTOME_ELONGATION_ARREST_AND_RECOVERY | Genes involved in Elongation arrest and recovery |
| 0.0 | 0.4 | REACTOME_REGULATION_OF_RHEB_GTPASE_ACTIVITY_BY_AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.0 | 0.2 | REACTOME_MICRORNA_MIRNA_BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
| 0.0 | 0.3 | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.0 | 0.3 | REACTOME_CALNEXIN_CALRETICULIN_CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.0 | 1.4 | REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 0.0 | 0.1 | REACTOME_SIGNALING_BY_ERBB2 | Genes involved in Signaling by ERBB2 |
| 0.0 | 0.1 | REACTOME_SEROTONIN_RECEPTORS | Genes involved in Serotonin receptors |
| 0.0 | 1.5 | REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION | Genes involved in PPARA Activates Gene Expression |
| 0.0 | 0.2 | REACTOME_G_ALPHA1213_SIGNALLING_EVENTS | Genes involved in G alpha (12/13) signalling events |
| 0.0 | 0.3 | REACTOME_SIGNALING_BY_FGFR1_FUSION_MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.0 | 0.9 | REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_ | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.0 | 0.5 | REACTOME_GLUTATHIONE_CONJUGATION | Genes involved in Glutathione conjugation |
| 0.0 | 0.1 | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | Genes involved in Integration of energy metabolism |
| 0.0 | 1.6 | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.0 | 0.1 | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
| 0.0 | 0.2 | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | Genes involved in G alpha (s) signalling events |
| 0.0 | 0.2 | REACTOME_METABOLISM_OF_POLYAMINES | Genes involved in Metabolism of polyamines |
|
|
|